...
search icon
abp-img

ABPRO CORP, Common Stock

ABP

NMQ

$0.215

-$0.02

(-8.65%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$12.78M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
2.03M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
-0.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.16 L
$13 H
$0.215

About ABPRO CORP, Common Stock

Abpro Holdings, Inc., a biotechnology company, focuses on novel antibody constructs for immuno-oncology and ophthalmology. Its platforms include DiversImmune, a discovery platform that generates a diverse collection of proprietary antibodies against clinically validated and novel targets; and MultiMab, an engineering platform that provides the flexibility to combine antibody building blocks in different combinations and orientations to create fit for purpose novel full-length multi-specific antibody constructs. The company's lead product candidates include ABP-102, a next generation immuno-oncology TetraBi antibody targeting HER2 and CD3 is developed for the treatment of HER2+ solid tumors, including breast and gastric cancers; and ABP-201, a TetraBi antibody format that simultaneously inhibit VEGF and ANG-2 for the treatment of vascular diseases of the eye, including diabetic macular edema and wet age-related macular degeneration. It also develops ABP-110, a TetraBi antibody targeting GPC3 and CD3 for the treatment of hepatocellular carcinoma; and ABP-150, a TetraBi antibody targeting claudin 18.2 and CD3 for the treatment of gastric cancers. The company has strategic partnership with Celltrion Inc. and Abpro Bio International, Inc. Abpro Holdings, Inc. was incorporated in 2004 and is headquartered in Woburn, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameABPSectorS&P500
1-Week Return5.34%1.81%0.78%
1-Month Return23.63%3.75%2.88%
3-Month Return-55.51%-4.88%9.45%
6-Month Return-86.12%-2.96%-0.12%
1-Year Return-98.07%-6.25%11.31%
3-Year Return-97.83%12.43%61.11%
5-Year Return-97.83%39.86%96.65%

Financials

Dec '17Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue2.20M480.00K2.03M122.00K183.00K[{"date":"2017-12-31","value":100,"profit":true},{"date":"2021-12-31","value":21.81,"profit":true},{"date":"2022-12-31","value":92.19,"profit":true},{"date":"2023-12-31","value":5.54,"profit":true},{"date":"2024-12-31","value":8.31,"profit":true}]
Cost of Revenue1.52M8.63M---[{"date":"2017-12-31","value":17.68,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit676.00K(8.15M)2.03M122.00K183.00K[{"date":"2017-12-31","value":33.32,"profit":true},{"date":"2021-12-31","value":-401.53,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":6.01,"profit":true},{"date":"2024-12-31","value":9.02,"profit":true}]
Gross Margin30.71%(1697.29%)100.00%100.00%100.00%[{"date":"2017-12-31","value":30.71,"profit":true},{"date":"2021-12-31","value":-1697.29,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Operating Expenses13.03M6.83M18.71M11.87M10.10M[{"date":"2017-12-31","value":69.64,"profit":true},{"date":"2021-12-31","value":36.5,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":63.42,"profit":true},{"date":"2024-12-31","value":53.99,"profit":true}]
Operating Income(12.36M)(14.98M)(16.68M)(11.75M)(9.92M)[{"date":"2017-12-31","value":-1235700000,"profit":false},{"date":"2021-12-31","value":-1497700000,"profit":false},{"date":"2022-12-31","value":-1668500000,"profit":false},{"date":"2023-12-31","value":-1174600000,"profit":false},{"date":"2024-12-31","value":-992100000,"profit":false}]
Total Non-Operating Income/Expense--(400.00K)80.00K2.31M[{"date":"2017-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-17.31,"profit":false},{"date":"2023-12-31","value":3.46,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(12.33M)(14.73M)(16.89M)(11.71M)(7.23M)[{"date":"2017-12-31","value":-1232600000,"profit":false},{"date":"2021-12-31","value":-1473500000,"profit":false},{"date":"2022-12-31","value":-1688500000,"profit":false},{"date":"2023-12-31","value":-1170600000,"profit":false},{"date":"2024-12-31","value":-723200000,"profit":false}]
Income Taxes31.00K-330.00K--[{"date":"2017-12-31","value":9.39,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes--(17.21M)--[{"date":"2017-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1721500000,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations--(17.21M)(11.71M)(7.23M)[{"date":"2017-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":-1721500000,"profit":false},{"date":"2023-12-31","value":-1170600000,"profit":false},{"date":"2024-12-31","value":-723200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2017-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(12.36M)(14.73M)(17.21M)(11.71M)(7.23M)[{"date":"2017-12-31","value":-1235700000,"profit":false},{"date":"2021-12-31","value":-1473500000,"profit":false},{"date":"2022-12-31","value":-1721500000,"profit":false},{"date":"2023-12-31","value":-1170600000,"profit":false},{"date":"2024-12-31","value":-723200000,"profit":false}]
EPS (Diluted)----(0.32)[{"date":"2017-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":-32,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ABP
Current Ratio 0.11

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ABP
ROA (LTM) -212.91%
ROE (LTM) 0.00%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ABP
Debt Ratio Lower is generally better. Negative is bad. 7.37
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. -6.56

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ABP
Trailing PE NM
Forward PE NM
P/S (TTM) 84.40
P/B 0.00
Price/FCF NM
EV/R 93.17
EV/Ebitda NM

FAQs

What is ABPRO CORP share price today?

ABPRO CORP (ABP) share price today is $0.215

Can Indians buy ABPRO CORP shares?

Yes, Indians can buy shares of ABPRO CORP (ABP) on Vested. To buy ABPRO CORP from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ABP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of ABPRO CORP be purchased?

Yes, you can purchase fractional shares of ABPRO CORP (ABP) via the Vested app. You can start investing in ABPRO CORP (ABP) with a minimum investment of $1.

How to invest in ABPRO CORP shares from India?

You can invest in shares of ABPRO CORP (ABP) via Vested in three simple steps:

  • Click on Sign Up or Invest in ABP stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in ABPRO CORP shares
What is ABPRO CORP 52-week high and low stock price?

The 52-week high price of ABPRO CORP (ABP) is $13. The 52-week low price of ABPRO CORP (ABP) is $0.16.

What is ABPRO CORP price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of ABPRO CORP (ABP) is 0.00

What is the Market Cap of ABPRO CORP?

The market capitalization of ABPRO CORP (ABP) is $12.78M

What is ABPRO CORP’s stock symbol?

The stock symbol (or ticker) of ABPRO CORP is ABP

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top